FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:158 January 14, 1999 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Arie Belldegrun, Roger S. Kirby, and R.T.D. Oliver. 429 pp., illustrated. Oxford, England, Isis Medical Media, 1998. (Distributed by Mosby, St. Louis.) $150. ISBN 1-899066-89-6.

As the population ages and deaths from preventable causes decline, prostate cancer will more commonly appear on medical-chart "problem lists" and — in the absence of effective therapy — on death certificates. Three facts emphasize the importance of understanding the biology, diagnosis, and treatment of prostate cancer. In the United States, a man has a one-in-five chance that invasive prostate cancer will develop during his lifetime. His chances that prostate cancer will be diagnosed are nearly twice that of lung cancer and three times that of colorectal cancer. The number of deaths due to prostate cancer, although they represent only . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.